Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
3,439,668
-
Share change
-
+3,439,668
-
Total reported value
-
$44,717,000
-
Price per share
-
$13.00
-
Number of holders
-
15
-
Value change
-
+$44,716,979
-
Number of buys
-
15
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2020
As of 31 Mar 2020,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,439,668 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., MANUFACTURERS LIFE INSURANCE COMPANY, THE, Sio Capital Management, LLC, Artisan Partners Limited Partnership, Artal Group S.A., MORGAN STANLEY, NS Partners Ltd, FRANKLIN RESOURCES INC, NORGES BANK, and SG Americas Securities, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.